This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
Leukemia Open Access 29 April 2010
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jaffe ES, Harris NL, Stein H, Vardiman J . Pathology and genetics. Tumours of Haematopoietic and Lymphoid tissues, 3rd edn. IARC: Lyon, Cedex, France, 2001, 58–59.
Boissinot M, Garand R, Hamidou M, Hermouet S . The JAK2-V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS). Blood 2006; 108: 1781–1782.
Renneville A, Quesnel B, Charpentier A, Terriou L, Crinquette A, Lai JL et al. High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis. Leukemia 2006; 20: 2067–2070.
Szpurka H, Tiu R, Murugesan G, Aboudola S, Hsi ED, Theil KS et al. Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation. Blood 2006; 108: 2173–2181.
Wang SA, Hasserjian RP, Loew JM, Sechman EV, Jones D, Hao S et al. Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features. Leukemia 2006; 20: 1641–1644.
Nussenzveig RH, Swierczek SI, Jelinek J, Gaikwad A, Liu E, Verstovsek S et al. Polycythemia vera is not initiated by JAK2 V617F mutation. Exp Hematol 2007; 35: 32–38.
Streeter RR, Presant CA, Reinhard E . Prognostic significance of thrombocytosis in idiopathic sideroblastic anemia. Blood 1977; 50: 427–432.
Shaw GR . Ringed sideroblasts with thrombocytosis: an uncommon mixed myelodysplastic/myeloproliferative disease of older adults. Br J Haematol 2005; 131: 180–184.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Atallah, E., Nussenzveig, R., Yin, C. et al. Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis. Leukemia 22, 1295–1298 (2008). https://doi.org/10.1038/sj.leu.2405054
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2405054
This article is cited by
-
Philadelphia-Negative Myeloproliferative Neoplasms: Laboratory Workup in the Era of Next-Generation Sequencing
Current Hematologic Malignancy Reports (2019)
-
Myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN, U): natural history and clinical outcome by treatment strategy
Leukemia (2014)
-
WHO Classification of Myeloproliferative Neoplasms (MPN): A Critical Update
Current Hematologic Malignancy Reports (2013)
-
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
Leukemia (2010)
-
Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World Health Organization criteria
International Journal of Hematology (2010)